Peter J. Felock

5.1k citations

46 papers · 3.3k indexed · 1 hit paper · h-index 25

Co-authors: Daria J. Hazuda Abigail Wolfe Marc Witmer Jay A. Grobler Amy S. Espeseth Kara A. Stillmock William A. Schleif Lori J. Gabryelski
Topics: HIV/AIDS drug development and treatment (35 papers)HIV Research and Treatment (28 papers)Biochemical and Molecular Research (19 papers)
Cited by: Virology Infectious Diseases Organic Chemistry
Journals: Science Proceedings of the National Academy of Sciences Journal of Molecular Biology
Partner nations: United States Spain Netherlands

In The Last Decade

Peter J. Felock

46 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells

2000 922 citations Daria J. Hazuda, Peter J. Felock et al. profile →

Peers

Countries citing papers authored by Peter J. Felock

Since Specialization

Citations

This map shows the geographic impact of Peter J. Felock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Felock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Felock more than expected).

Fields of papers citing papers by Peter J. Felock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Felock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Felock. The network helps show where Peter J. Felock may publish in the future.

Co-authorship network of co-authors of Peter J. Felock

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Felock. A scholar is included among the top collaborators of Peter J. Felock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Felock. Peter J. Felock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antiviral Activity andIn VitroMutation Development Pathways of MK-6186, a Novel Nonnucleoside Reverse Transcriptase Inhibitor 2012 ·Antimicrobial Agents and Chemotherapy ·Meiqing Lu,Peter J. Felock,Vandna Munshi,Renee Hrin,Yingjie Wang,Youwei Yan,Sanjeev Munshi,Georgia B. McGaughey,Robert Gomez,Neville J. Anthony,Theresa M. Williams,Jay A. Grobler,Daria J. Hazuda,Philip M. McKenna,Michael D. Miller,Ming‐Tain Lai	13
2	Assessment of the susceptibility of mutant HIV-1 to antiviral agents 2010 ·Journal of Virological Methods ·Yingjie Wang,Philip M. McKenna,Renee Hrin,Peter J. Felock,Meiqing Lu,(unknown),Craig A. Coburn,Jay A. Grobler,Daria J. Hazuda,Michael D. Miller,Ming‐Tain Lai	10
3	Triple Hyp→Pro replacement in integramide A, a peptaib inhibitor of HIV‐1 integrase: Effect on conformation and bioactivity 2010 ·Biopolymers ·Marta De Zotti,Wim M. De Borggraeve,Bernard Kaptein,Quirinus B. Broxterman,Sheo B. Singh,Peter J. Felock,Daria J. Hazuda,Fernando Formaggio,Claudio Toniolo	2
4	Total Synthesis, Characterization, and Conformational Analysis of the Naturally Occurring Hexadecapeptide Integramide A and a Diastereomer 2009 ·Chemistry - A European Journal ·Marta De Zotti,(unknown),Fernando Formaggio,Marco Crisma,Elisabetta Schievano,Stefano Mammi,Bernard Kaptein,Quirinus B. Broxterman,Peter J. Felock,Daria J. Hazuda,Sheo B. Singh,Jochen Kirschbaum,Hans Brückner,Claudio Toniolo	16
5	Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase 2008 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey Y. Melamed,Melissa S. Egbertson,Sándor Varga,Joseph P. Vacca,(unknown),Lori J. Gabryelski,Peter J. Felock,Kara A. Stillmock,Marc Witmer,William A. Schleif,Daria J. Hazuda,Yvonne Leonard,Lixia Jin,Joan D. Ellis,Steven D. Young	20
6	8-Hydroxy-3,4-dihydropyrrolo[1,2-a]pyrazine-1(2H)-one HIV-1 integrase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Thorsten E. Fisher,Bo-Young Kim,(unknown),Terry A. Lyle,Steven D. Young,Joseph P. Vacca,Matthew M. Zrada,Daria J. Hazuda,Peter J. Felock,William A. Schleif,Lori J. Gabryelski,M. Reza Anari,Christopher J. Kochansky,John Wai	31
7	Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Peter Williams,Carl F. Homnick,Joseph P. Vacca,Peter J. Felock,Kara A. Stillmock,Marc Witmer,Daria J. Hazuda,Lori J. Gabryelski,William A. Schleif	13
8	Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·John Wai,Bo Young Kim,Thorsten E. Fisher,Linghang Zhuang,Mark W. Embrey,Peter Williams,(unknown),Chris Culberson,Terry A. Lyle,Joseph P. Vacca,Daria J. Hazuda,Peter J. Felock,William A. Schleif,Lori J. Gabryelski,Lixia Jin,I‐Wu Chen,Joan D. Ellis,(unknown),Steven D. Young	21
9	A series of 5-aminosubstituted 4-fluorobenzyl-8-hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·James P. Guare,John Wai,Robert Gomez,Neville J. Anthony,Samson M. Jolly,(unknown),Joseph P. Vacca,Peter J. Felock,Kara A. Stillmock,William A. Schleif,Gregory Moyer,Lori J. Gabryelski,Lixia Jin,I‐Wu Chen,Daria J. Hazuda,Steven D. Young	37
10	Four novel bis-(naphtho-γ-pyrones) isolated from Fusarium species as inhibitors of HIV-1 integrase 2003 ·Bioorganic & Medicinal Chemistry Letters ·Sheo B. Singh,Deborah L. Zink,Gerald F. Bills,Ana Teran,Keith C. Silverman,Russell B. Lingham,Peter J. Felock,Daria J. Hazuda	37
11	Isolation, Structure and HIV-1 Integrase Inhibitory Activity of Exophillic Acid, a Novel Fungal Metabolite from Exophiala pisciphila 2003 ·The Journal of Antibiotics ·John G. Ondeyka,Deborah L. Zink,Anne W. Dombrowski,Jon D. Polishook,Peter J. Felock,Daria J. Hazuda,Sheo B. Singh	21
12	Isolation, Structure, and HIV-1 Integrase Inhibitory Activity of Cytosporic Acid, a Fungal Metabolite Produced by a Cytospora sp. 2003 ·Journal of Natural Products ·Hiranthi Jayasuriya,Ziqiang Guan,Jon D. Polishook,Anne W. Dombrowski,Peter J. Felock,Daria J. Hazuda,Sheo B. Singh	28
13	Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected Cells 2003 ·Journal of Medicinal Chemistry ·Linghang Zhuang,John Wai,Mark W. Embrey,Thorsten E. Fisher,Melissa S. Egbertson,Linda S. Payne,James P. Guare,Joseph P. Vacca,Daria J. Hazuda,Peter J. Felock,Abigail Wolfe,Kara A. Stillmock,Marc Witmer,Gregory Moyer,William A. Schleif,Lori J. Gabryelski,Yvonne Leonard,Joseph J. Lynch,Stuart R. Michelson,Steven D. Young	219
14	Integracides: tetracyclic triterpenoid inhibitors of HIV-1 integrase produced by Fusarium sp. 2003 ·Bioorganic & Medicinal Chemistry ·Sheo B. Singh,Deborah L. Zink,Anne W. Dombrowski,Jon D. Polishook,John G. Ondeyka,J. HIRSHFIELD,Peter J. Felock,Daria J. Hazuda	22
15	X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293) - an initial glance of the viral DNA binding platform 1 1Edited by I. A. Wilson 2000 ·Journal of Molecular Biology ·Zhongguo Chen,Youwei Yan,Sanjeev Munshi,Ying Li,Joan Zugay-Murphy,(unknown),Marc Witmer,Peter J. Felock,Abigail Wolfe,Vinod Sardana,Emilio A. Emini,(unknown),Lawrence C. Kuo	89
16	Chemical and enzymatic modifications of integric acid and HIV-1 integrase inhibitory activity 2000 ·Bioorganic & Medicinal Chemistry Letters ·Sheo B. Singh,Peter J. Felock,Daria J. Hazuda	30
17	HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase 2000 ·Proceedings of the National Academy of Sciences ·Amy S. Espeseth,Peter J. Felock,Abigail Wolfe,Marc Witmer,Jay A. Grobler,Neville J. Anthony,Melissa S. Egbertson,Jeffrey Y. Melamed,Steve Young,Terence G. Hamill,James L. Cole,Daria J. Hazuda	260
18	Structures of four methyltetrazole-containing antiviral compounds in human rhinovirus serotype 14 1995 ·Acta Crystallographica Section D Biological Crystallography ·Vincent L. Giranda,Giovanni Russo,Peter J. Felock,T. R. Bailey,(unknown),David Aldous,Joseph W. Guiles,Frank J. Dutko,G. D. DIANA,Daniel C. Pevear,Minnie McMillan	6
19	Crystal structure of human rhinovirus serotype 1A (HRV1A) 1989 ·Journal of Molecular Biology ·Sangsoo Kim,Thomas J. Smith,Michael S. Chapman,Michael G. Rossmann,Daniel C. Pevear,Frank J. Dutko,Peter J. Felock,Guy D. Diana,Mark A. McKinlay	161
20	Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors 1989 ·Journal of Virology ·D.C. Pevear,(unknown),Peter J. Felock,Michael G. Rossmann,Mark Steven Miller,G. D. DIANA,Adi M. Treasurywala,M A McKinlay,Frank J. Dutko	151

About Peter J. Felock

Peter J. Felock is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 46 papers that have together received 3.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (35 papers), HIV Research and Treatment (28 papers) and Biochemical and Molecular Research (19 papers). The work is most often cited by research in Virology (1.8k citations), Infectious Diseases (2.1k citations) and Organic Chemistry (726 citations). Peter J. Felock has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Daria J. Hazuda, Abigail Wolfe, Marc Witmer, Jay A. Grobler, Amy S. Espeseth, Kara A. Stillmock, William A. Schleif, Lori J. Gabryelski, Michael D. Miller and Sheo B. Singh. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact